Epstein Secrets

1990 and 1992 and subsequently joined the World Bank where he was involved in the development of the financial sector in Russia. Boris Nlkolk Dr. Boris Nikolic is a Chief Advisor for Science and Technology to Bill Gates at Bill Gates Catalyst 3 (bgc3), Bill Gates Ventures (BGV) and at the Bill & Melinda Gat

Science and Technology to Bill Gates at Bill Gates Catalyst 3 (bgc3), Bill Gates Ventures (BGV) and at the Bill & Melinda Gates Foundation (BMGF). Boris has led investment activities at these Gates-affiliated organizations on both the for-profit and non-for-profit aspects of Bill Gates' activities.

ceived his MD from Zagreb Medical School and his clinical training from the University's Medical Center, University of Zagreb, Croatia. In 1994, Dr. Nikolic joined the Harvard Graduate Program in Immunology. Subsequently, Boris continued to serve in roles of increasing authority including postdoctoral f

t hard-to-drug targets. Nimbus Discovery harnesses cutting-edge computational technologies to uncover breakthroughs in small molecule pharmacology. Nimbus focuses on medically important and highly sought-after disease targets that have proven inaccessible to traditional industry approaches. Nimbus' rob

the for-profit side, Boris led investments in various life science/health care companies such as Foundation Medicine, Research Gate, Schrodinger and Nimbus through Bill Gates Ventures. On the non-for profit side, Boris co-managed BMGF's $1.5 billion strategic investment pool focused on program-related

"Schrodinger") was held at the above place and time. Mr. Ardai, presiding as Chairman of the meeting, conducted a roll call and confirmed that Mr. Nikolic, Mr. Farid, Mr. Salkind and Mr. Friesner were present, and, finding a quorum had been established, called to order the meeting. Each member of the B

nference BOARD MEMBERS Charles Ardai PRESENT: Boris Nikolic Lou Salkind (by phone) Ramy Farid Richard Frie

nference BOARD MEMBERS Charles Ardai PRESENT: Boris Nikolic Lou Salkind (by phone) Ramy Farid Rich

ined by Nimbus Discovery, LLC ("Nimbus") in mid-January 2014. Ms. Tran informed the Board that (i) the bridge investors' equity would sit on top of Nimbus' existing investors' equity such that the bridge investors would be paid out in the event of a distribution of proceeds by Nimbus and that (ii) the

professionals as needed, from time to time. Boris Nikolic Boris Nikolic is a Managing Director of the General Partner of Biosys. Most recently, Dr. Boris Nikolic served as Chief Advisor for Science and Technology to Bill Gates at bgC3, the private office of Bill Gates, and at the Bill & Melinda Gates Foundati

nvestment team will initially be composed of Boris Nikolic, Hayes Nuss, Peter Corsell and David Schwarz (the "Investment Committee"). We expect that Boris will lead the sourcing, diligence, evaluation and monitoring of portfolio investments. We expect that Hayes will support with investment analysis a

f Advisor for Science and Technology to Bill Gates at bgC3, the private office of Bill Gates, and at the Bill & Melinda Gates Foundation (BMGF). Dr. Nikolic joined the BMGF in October 2007 and bgC3 in April 2010. Dr. Nikolic has led select for-profit and not-for-profit investment activities at the afore

life- science/IT/healthcare companies such as Foundation Medicine and Research Gate, served on the board of directors of Schrodinger, and monitored Nimbus. On the not-for-profit side, Dr. Nikolic co- managed BMGF's $1.5 billion strategic-investment pool, focused on program-related investments in health